Robert Califf, FDA commissioner (Graeme Sloan/Sipa USA)(Sipa via AP Images)

Can post-mar­ket ev­i­dence gen­er­a­tion be stream­lined? FDA-com­mis­sioned re­port pro­pos­es so­lu­tions

As the FDA seeks to bring a greater fo­cus to im­prov­ing post-mar­ket ev­i­dence gen­er­a­tion, a new re­port from the Rea­gan-Udall Foun­da­tion of­fers …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.